Trimetazidine Efficacy in Attenuating Paclitaxel-Induced Peripheral Neuropathy
Status:
COMPLETED
Trial end date:
2025-03-27
Target enrollment:
Participant gender:
Summary
This proof-of-concept study evaluated the effect of Trimetazidine on the incidence of paclitaxel-induced peripheral neuropathy in patients with breast cancer.